Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
vyepti 100 mg/ml solution à diluer pour perfusion
lundbeck (schweiz) ag - eptinezumabum - solution à diluer pour perfusion - eptinezumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 40.5 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika
Canada -
français -
Health Canada
vyepti solution
lundbeck canada inc - eptinézumab - solution - 100mg - eptinézumab 100mg - calcitonin-gene-related peptide (cgrp) antagonists
Canada -
français -
Health Canada
vyepti solution
lundbeck canada inc - eptinézumab - solution - 300mg - eptinézumab 300mg
Union européenne -
français -
EMA (European Medicines Agency)
vyepti
h. lundbeck a/s - eptinezumab - troubles de la migraine - analgésiques - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.